Large international study finds nearly half of patients admitted with visible blood in urine receive no imaging, delaying ...

The manufacturer of the interleukin-23 inhibitor tildrakizumab (Ilumya), Sun Pharma, announced today that the FDA has ...

The American College of Physicians says the term ‘provider’ blurs lines between nurse practitioners and physicians, confuses ...

Integrative clinics reflect a broader movement to close the long-standing gap between cardiovascular medicine and mental ...

A valved holding chamber with high drug delivery performance may reduce wheezing severity and hospitalizations more ...

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on ...

Invented by users and refined by engineers, wheelchairs now span €200 hospital loans to €30,000 custom models — a spectrum ...

Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...

Patients with IBD may experience increased serum levels of vitamin D with supplementation, but improvement in disease ...

A consortium of telehealth companies and insurers has published its ‘National Telehealth Standards,’ but some question the document’s impact.

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Despite a high degree of worry about COVID and experience with severe, long-lasting symptoms, high-risk patients often do not ...